MYC and B-cell non-Hodgkin lymphoma: Altogether, these results demonstrate a potentiation of the antitumoral activity of IACS‐010759 by ascorbate on Myc‐overexpressing B‐cell lymphoma, identifying redox homeostasis as a valid therapeutic target to treat this type of cancer.